Cargando…

Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study

OBJECTIVE: To determine 5-year survival in patients with colorectal cancer (CRC) according to patient and tumor characteristics. METHODS: Longitudinal study based on incident cases of invasive CRC between 2008 and 2017 captured by the Manizales Population-based Cancer Registry (n=850). Patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán-Gallego, Eduardo Antonio, Arias-Ortiz, Nelson Enrique, Rodríguez-Betancourt, Juan David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Saúde Coletiva 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511025/
https://www.ncbi.nlm.nih.gov/pubmed/37729347
http://dx.doi.org/10.1590/1980-549720230040
_version_ 1785108063164825600
author Guzmán-Gallego, Eduardo Antonio
Arias-Ortiz, Nelson Enrique
Rodríguez-Betancourt, Juan David
author_facet Guzmán-Gallego, Eduardo Antonio
Arias-Ortiz, Nelson Enrique
Rodríguez-Betancourt, Juan David
author_sort Guzmán-Gallego, Eduardo Antonio
collection PubMed
description OBJECTIVE: To determine 5-year survival in patients with colorectal cancer (CRC) according to patient and tumor characteristics. METHODS: Longitudinal study based on incident cases of invasive CRC between 2008 and 2017 captured by the Manizales Population-based Cancer Registry (n=850). Patients were followed up to August 24(th), 2021. Cause-specific survival and net survival were calculated for sociodemographic and tumor characteristics, and Cox multivariate was fitted. RESULTS: Fifty-five percent of cases occurred in women. The most frequent histological type was adenocarcinoma (78.2%). The most frequent locations were rectum (32.0%), ascending colon (16.6%), and sigmoid (16.2%). Twenty-five percent of cases were diagnosed in stage IV. There were 567 deaths due to CRC. The 5-year specific survival was 45.8% (95%CI 42.4–49.3), with independent effects for age (HR=1.83; 95%CI 1.26–2.65 age >75 years vs. <50 years) and advanced clinical stage (HR=2.5 and HR 5.7 for stages III and IV vs. stage I, respectively). Lower survival was observed in patients of medium socioeconomic status compared with higher socioeconomic status (HR=1.52; 95%CI 1.08–2.14), but not in patients of low socioeconomic status. No independent effects were observed for the health insurance regime. CONCLUSIONS: In Manizales, approximately 5 out of 10 patients with invasive CRC die in the first five years after diagnosis, with a lower survival in patients older than 75 years, from medium socioeconomic level and diagnosed in advanced clinical stages.
format Online
Article
Text
id pubmed-10511025
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Associação Brasileira de Saúde Coletiva
record_format MEDLINE/PubMed
spelling pubmed-105110252023-09-21 Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study Guzmán-Gallego, Eduardo Antonio Arias-Ortiz, Nelson Enrique Rodríguez-Betancourt, Juan David Rev Bras Epidemiol Original Article OBJECTIVE: To determine 5-year survival in patients with colorectal cancer (CRC) according to patient and tumor characteristics. METHODS: Longitudinal study based on incident cases of invasive CRC between 2008 and 2017 captured by the Manizales Population-based Cancer Registry (n=850). Patients were followed up to August 24(th), 2021. Cause-specific survival and net survival were calculated for sociodemographic and tumor characteristics, and Cox multivariate was fitted. RESULTS: Fifty-five percent of cases occurred in women. The most frequent histological type was adenocarcinoma (78.2%). The most frequent locations were rectum (32.0%), ascending colon (16.6%), and sigmoid (16.2%). Twenty-five percent of cases were diagnosed in stage IV. There were 567 deaths due to CRC. The 5-year specific survival was 45.8% (95%CI 42.4–49.3), with independent effects for age (HR=1.83; 95%CI 1.26–2.65 age >75 years vs. <50 years) and advanced clinical stage (HR=2.5 and HR 5.7 for stages III and IV vs. stage I, respectively). Lower survival was observed in patients of medium socioeconomic status compared with higher socioeconomic status (HR=1.52; 95%CI 1.08–2.14), but not in patients of low socioeconomic status. No independent effects were observed for the health insurance regime. CONCLUSIONS: In Manizales, approximately 5 out of 10 patients with invasive CRC die in the first five years after diagnosis, with a lower survival in patients older than 75 years, from medium socioeconomic level and diagnosed in advanced clinical stages. Associação Brasileira de Saúde Coletiva 2023-09-18 /pmc/articles/PMC10511025/ /pubmed/37729347 http://dx.doi.org/10.1590/1980-549720230040 Text en https://creativecommons.org/licenses/by/4.0/All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License
spellingShingle Original Article
Guzmán-Gallego, Eduardo Antonio
Arias-Ortiz, Nelson Enrique
Rodríguez-Betancourt, Juan David
Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study
title Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study
title_full Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study
title_fullStr Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study
title_full_unstemmed Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study
title_short Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study
title_sort colorectal cancer survival in manizales, colombia, 2008-2017: a population-based study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511025/
https://www.ncbi.nlm.nih.gov/pubmed/37729347
http://dx.doi.org/10.1590/1980-549720230040
work_keys_str_mv AT guzmangallegoeduardoantonio colorectalcancersurvivalinmanizalescolombia20082017apopulationbasedstudy
AT ariasortiznelsonenrique colorectalcancersurvivalinmanizalescolombia20082017apopulationbasedstudy
AT rodriguezbetancourtjuandavid colorectalcancersurvivalinmanizalescolombia20082017apopulationbasedstudy